Sign up to follow @Novartis at http://twitter.com/novartis. The Board comprises 14 members with Joerg Reinhardt as chairman. News; Newsletter; Resources Library; Publications; Stay in Touch; Search. Joerg Reinhardt, Ph.D. Chairman. Head of the Novartis Foundation. Accelerating leprosy elimination; Enhancing heart health in low-income communities; Reimagining healthcare through digital technology; Maturing Programs; Stories; Media Center. For more information, please visit http://www.novartis.com. In 2014, the Group achieved net sales of USD 58.0 billion, while R&D throughout the Group amounted to approximately USD 9.9 billion (USD 9.6 billion excluding impairment and amortization charges). Ann Aerts, M.D. Such forward-looking statements reflect the current views of the Group regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results expressed or implied by such statements. In 2014, the operational budget for the foundation was CHF 12 million and our programs reached 3.6 million people. We work hand-in-hand with our local and global partners to accelerate elimination of leprosy and malaria by focusing on interventions that aim to interrupt transmission, and to catalyze scalable and sustainable healthcare models to improve access and health outcomes. Mr. Juergen Brokatzky-Geiger, Global Head of Corporate Responsibility for Novartis, and Dr. Ann Aerts, Head of the Novartis Foundation, will remain on the Novartis Foundation Board. Previous Board members Mr. George Gunn and Prof. Dr. Jean-Marie Lehn stepped down in the past year. DisclaimerThis press release contains expressed or implied forward-looking statements, including statements that can be identified by terminology such as "will," "committed," "to improve," "to empower," "can," "to accelerate," "to improve," or similar expressions. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update it in the future. Read biography (PDF 122 KB) Jo Ivey Boufford. Board of Trustees; Our Team; Our Partners; Our Work. For Novartis multimedia content, please visit www.thenewsmarket.com/Novartis For questions about the site or required registration, please contact: [email protected]. Mr. Juergen Brokatzky-Geiger, Global Head of Corporate Responsibility for Novartis, and Dr. Ann Aerts, Head of the Novartis Foundation, will remain on the Novartis Foundation Board. Read biography (PDF 32 KB) Ann Aerts. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. In recent years, we focused on programmatic work that reached over 30 million people, plus health outcomes research, and the translation of new evidence into health policy.